BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30444557)

  • 1. Locals get travellers' diarrhoea too: risk factors for diarrhoeal illness and pathogenic Escherichia coli infection across an urban-rural gradient in Ecuador.
    Smith SM; Montero L; Paez M; Ortega E; Hall E; Bohnert K; Sanchez X; Puebla E; Endara P; Cevallos W; Trueba G; Levy K
    Trop Med Int Health; 2019 Feb; 24(2):205-219. PubMed ID: 30444557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Travellers' diarrhoea: contemporary approaches to therapy and prevention.
    DuPont HL
    Drugs; 2006; 66(3):303-14. PubMed ID: 16526819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance profiles of diarrhoeagenic
    Boxall MD; Day MR; Greig DR; Jenkins C
    J Med Microbiol; 2020 Jul; 69(7):932-943. PubMed ID: 32530393
    [No Abstract]   [Full Text] [Related]  

  • 4. Population genomics of diarrheagenic Escherichia coli uncovers high connectivity between urban and rural communities in Ecuador.
    Rothstein AP; Jesser KJ; Feistel DJ; Konstantinidis KT; Trueba G; Levy K
    Infect Genet Evol; 2023 Sep; 113():105476. PubMed ID: 37392822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea.
    Paschke C; Apelt N; Fleischmann E; Perona P; Walentiny C; Löscher T; Herbinger KH
    Clin Microbiol Infect; 2011 Aug; 17(8):1194-200. PubMed ID: 21054662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of acquisition of human diarrhoeagenic Escherichia coli virulence genes in intercontinental travellers: A prospective, multi-centre study.
    van Hattem JM; Cabal A; Arcilla MS; Alvarez J; de Jong MD; Melles DC; Penders J; ; Schmidt CG; Schultsz C
    Travel Med Infect Dis; 2019; 31():101362. PubMed ID: 30609386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia.
    Kuenzli E; Juergensen D; Kling K; Jaeger VK; DeCrom S; Steffen R; Widmer AF; Battegay M; Hatz C; Neumayr A
    J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28931148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aetiology of diarrhoea and virulence properties of diarrhoeagenic Escherichia coli among patients and healthy subjects in southeast Nigeria.
    Nweze EI
    J Health Popul Nutr; 2010 Jun; 28(3):245-52. PubMed ID: 20635635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of travellers' diarrhoea: analysis of pathogen findings by destination in various (sub)tropical regions.
    Lääveri T; Vilkman K; Pakkanen SH; Kirveskari J; Kantele A
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e9-908.e16. PubMed ID: 29133155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited.
    Lääveri T; Antikainen J; Pakkanen SH; Kirveskari J; Kantele A
    Clin Microbiol Infect; 2016 Jun; 22(6):535-41. PubMed ID: 26970046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of Escherichia coli Pathotypes along an Urban-Rural Gradient in Ecuador.
    Montero L; Smith SM; Jesser KJ; Paez M; Ortega E; Peña-Gonzalez A; Soto-Girón MJ; Hatt JK; Sánchez X; Puebla E; Endara P; Cevallos W; Konstantinidis KT; Trueba G; Levy K
    Am J Trop Med Hyg; 2023 Sep; 109(3):559-567. PubMed ID: 37549901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
    Behrens RH; Cramer JP; Jelinek T; Shaw H; von Sonnenburg F; Wilbraham D; Weinke T; Bell DJ; Asturias E; Pauwells HL; Maxwell R; Paredes-Paredes M; Glenn GM; Dewasthaly S; Stablein DM; Jiang ZD; DuPont HL
    Lancet Infect Dis; 2014 Mar; 14(3):197-204. PubMed ID: 24291168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.
    Kuenzli E; Jaeger VK; Frei R; Neumayr A; DeCrom S; Haller S; Blum J; Widmer AF; Furrer H; Battegay M; Endimiani A; Hatz C
    BMC Infect Dis; 2014 Oct; 14():528. PubMed ID: 25270732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carriage of diarrhoeagenic Escherichia coli by older children and adults in Accra, Ghana.
    Opintan JA; Bishar RA; Newman MJ; Okeke IN
    Trans R Soc Trop Med Hyg; 2010 Jul; 104(7):504-6. PubMed ID: 20307897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Travellers' diarrhoea: Impact of TD definition and control group design on study results.
    Lääveri T; Pakkanen SH; Kirveskari J; Kantele A
    Travel Med Infect Dis; 2018; 24():37-43. PubMed ID: 29409749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.
    Tham J; Odenholt I; Walder M; Brolund A; Ahl J; Melander E
    Scand J Infect Dis; 2010 Apr; 42(4):275-80. PubMed ID: 20121649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
    López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
    Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic Signatures of Gut Infections Caused by Different
    Peña-Gonzalez A; Soto-Girón MJ; Smith S; Sistrunk J; Montero L; Páez M; Ortega E; Hatt JK; Cevallos W; Trueba G; Levy K; Konstantinidis KT
    Appl Environ Microbiol; 2019 Dec; 85(24):. PubMed ID: 31585992
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.
    Rademaker CM; Krul MR; Jansen WH; Vos NM; Hoepelman IM; Rozenberg-Arska M; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):625-9. PubMed ID: 1748115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of heat-labile and heat-stable toxin-producing enterotoxigenic Escherichia coli: A prospective study among Finnish travellers.
    Turunen K; Antikainen J; Lääveri T; Kirveskari J; Svennerholm AM; Kantele A
    Travel Med Infect Dis; 2020; 38():101855. PubMed ID: 32846225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.